For the quarter ended September 2025, OPKO Health (OPK Quick QuoteOPK - Free Report) reported revenue of $151.7 million, down 12.6% over the same period last year. EPS came in at $0.03, compared to $0.03 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $157.11 million, representing a surprise of -3.44%. The company delivered an EPS surprise of +250%, with the consensus EPS estimate being -$0.02.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how OPKO Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Revenue from services: $95.2 million compared to the $96.86 million average estimate based on four analysts. The reported number represents a change of -21.5% year over year.
• Revenues- Revenue from transfer of intellectual property and other: $18.8 million versus $18.46 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +42.4% change.
• Revenues- Revenue from products: $37.7 million compared to the $41.79 million average estimate based on four analysts. The reported number represents a change of -3.6% year over year.

View all Key Company Metrics for OPKO Health here>>>

Shares of OPKO Health have returned -7.1% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.